Biomerica (BMRA) Gross Margin (2010 - 2026)

Biomerica has disclosed Gross Margin across 17 years of filings, most recently posting 4.46% for Q1 2026.

• Gross Margin for Q1 2026 came in at 4.46%, down 616.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 4.32% (down 915.0% YoY), and the FY2025 annual result was 9.38%, down 191.0% from the prior year.
• Gross Margin came in at 4.46% for Q1 2026 at Biomerica, down from 4.21% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 30.72% in Q3 2025 to a low of 32.58% in Q2 2025.
• The 5-year median for Gross Margin is 10.8% (2023), against an average of 8.33%.
• Across the five-year window, Gross Margin soared 2741 bps in 2023 and slumped 3437 bps in 2025, its largest moves.
• Biomerica's Gross Margin stood at 23.75% in 2022, then slipped by 13 bps to 20.74% in 2023, then gained by 29 bps to 26.71% in 2024, then tumbled by 84 bps to 4.21% in 2025, then sank by 206 bps to 4.46% in 2026.
• The last three Gross Margin figures came in at 4.46% (Q1 2026), 4.21% (Q4 2025), and 30.72% (Q3 2025), per Business Quant data.